Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline.
Raza Syed HodaAnita S BowmanAhmet ZehirPedram RazaviEdi BrogiMarc LadanyiMaria E ArcilaHannah Y WenDara S RossPublished in: Histopathology (2020)
Our NGS findings support the reclassification of HER2 FISH-equivocal cases as HER2-negative under the 2018 ASCO/CAP guideline.